Showing results (121-130 of 355) with videos related to

Sort By:
Pageof 36
Journal of the American College of Cardiology|March 27, 2024
Sacubitril/Valsartan-Related Hypotension in Patients With Heart Failure and Preserved or Mildly Reduced Ejection FractionAlberto Foà, Muthiah Vaduganathan, Brian L Claggett, et al.
Circulation|December 28, 2018
Refining Prediction of Atrial Fibrillation-Related Stroke Using the P2-CHA2DS2-VASc ScoreAnkit Maheshwari, Faye L Norby, Nicholas S Roetker, et al.
European Journal of Heart Failure|February 13, 2018
Effect of sacubitril/valsartan on recurrent events in the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARADIGM-HF)Ulrik M Mogensen, Jianjian Gong, Pardeep S Jhund, et al.
JACC. Heart Failure|June 27, 2025
Linking Chronic Kidney Disease to Incident Heart Failure and Adverse Cardiac Remodeling Through the Plasma Proteome: The ARIC StudyLeo F Buckley, Pranav Dorbala, Victoria Lamberson, et al.
Journal of Cardiac Failure|December 8, 2023
Effect of Eplontersen on Cardiac Structure and Function in Patients With Hereditary Transthyretin AmyloidosisAhmad Masri, Mathew S Maurer, Brian L Claggett, et al.
JACC. Heart Failure|June 6, 2024
Sacubitril/Valsartan in Patients With Heart Failure and Deterioration in eGFR to 2Safia Chatur, Iris E Beldhuis, Brian L Claggett, et al.
European Journal of Heart Failure|March 2, 2026
Efficacy of finerenone in patients with heart failure and mildly reduced or preserved ejection fraction: a prespecified analysis of heart rate and heart rhythm in the FINEARTS-HF trialMisato Chimura, Pardeep S Jhund, Alasdair D Henderson, et al.
European Journal of Heart Failure|July 4, 2023
Changes in mid-regional pro-adrenomedullin during treatment with sacubitril/valsartanPeder L Myhre, Yuxi Liu, Ian J Kulac, et al.
JACC. Heart Failure|March 5, 2018
Sudden Death in Heart Failure With Preserved Ejection Fraction: A Competing Risks Analysis From the TOPCAT TrialMuthiah Vaduganathan, Brian L Claggett, Neal A Chatterjee, et al.
JAMA Cardiology|June 3, 2026
Finerenone Across Cardiovascular-Kidney-Metabolic Syndrome Stages: Post Hoc Analysis of the FIDELITY Randomized Clinical TrialsKevin Bryan Lo, John W Ostrominski, Yasuhiro Hamatani, et al.
Pageof 36